In reply: Teschke questions the temporal sequence in our reported case1 by raising an ambiguity in dates. We wish to clarify: when the patient first presented on 23 May 2006, lethargy, arthralgia and nausea had been present for only about 3 weeks. This was well after the dose increase in black cohosh in March 2006. As such, the dose escalation definitely preceded the patient’s symptoms and liver failure.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Department of Gastroenterology and Hepatology, Flinders Medical Centre, Adelaide, SA.
Correspondence: elizabeth.chow@fmc.sa.gov.au
- 1. Chow ECY, Teo M, Ring JA, Chen JW. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 2008; 188: 420-422. <MJA full text>
- 2. Joy D, Joy J, Duane P. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric 2008; 11: 84-88.
- 3. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). London: EMEA, 2007. http://www.emea.europa. eu/pdfs/human/hmpc/26925806en.pdf (accessed Oct 2008).
- 4. Lüde S, Török M, Dieterle S, et al. Hepatic effects of Cimifuga racemosa extract in vivo and in vitro. Cell Mol Life Sci 2007; 64: 2848-2857.
- 5. Australian Government Department of Health and Ageing Therapuetic Goods Administration. Required advisory statements for medicine labels. Proposed update 3.1, consultation document. Canberra: Australian Government, 2007. http://www.tga.gov.au/meds/drrasmlupd3-1.pdf (accessed Oct 2008).
- 6. Medicines and Healthcare Products Regulatory Agency. Black cohosh. UK Public Assessment Report, 31 Jul 2006. http://www.mhra.gov.uk/home/groups/es-herbal/documents/websiteresources/con2024279.pdf (accessed Oct 2008).
- 7. Health Canada. Health Canada is advising consumers about a possible link between black cohosh and liver damage [advisory]. Ottawa: Health Canada, 2006. http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2006/2006_72_e.html (accessed Sep 2006).
Online responses are no longer available. Please refer to our instructions for authors page for more information.